Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ACTRN12625000698471) titled 'Personalising Aotearoa Lupus Medications: investigation of biomarkers for individualisation of therapy' on July 1.
Study Type: Observational
Study Design:
Purpose: Screening
Duration: Cross-sectional
Selection: Defined population
Timing: Prospective
Primary Sponsor: Waipapa Taumata Rau, the University of Auckland
Condition:
Systemic lupus erythematosus (SLE)
Lupus nephritis
Systemic lupus erythematosus (SLE)
Lupus nephritis
Inflammatory and Immune System - Autoimmune diseases
Renal and Urogenital - Kidney disease
Intervention:
SLE Patients
Whole blood samples will be collected from SLE patients aged 1...